Device Wound Closure

Caprosyn

Payments companies reported to CMS as associated with Caprosyn. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$880associated payments (2023-2025)

14clinicians with associated payments

1company reporting

By year

2023 $827

2024 $53.58

Payments reported as associated with Caprosyn, per program year, as reported to CMS.

Who makes it

Medtronic, INC. $880 associated with Caprosyn (2023-2025)

Specialties most often involved

Surgery $526

General Practice $75.17

Gynecology $75.16

Vascular Surgery $75.16

Thoracic Surgery (Cardiothoracic Vascular Surgery) $75.16

Physician Assistant $35.72

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Caprosyn

These are the largest totals companies reported as associated with Caprosyn. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Eduardo Padilla Gonzalez	San Juan, PR	General Practice	$75.17
Osvaldo Cardona Gonzalez	Mayaguez, PR	Surgery	$75.17
Aihab Aboukheir Aboukheir	Pittsburgh, PA	Surgery	$75.17
Patricia Mulero Soto	Carolina, PR	Surgery	$75.16
Omar Rovira Bellido	Mayaguez, PR	Surgery	$75.16
Anabelle Ortiz-Rivera	Ponce, PR	Gynecology	$75.16
Hector Lopez Gonzalez	Ponce, PR	Surgery	$75.16
Jorge Martinez Trabal	Ponce, PR	Vascular Surgery	$75.16
Javier Ruiz Aburto	Ponce, PR	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$75.16
Sheila Perez Canales	Mayaguez, PR	Surgery	$75.16

Prescribed Caprosyn?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.